NEW YORK, February 21, 2017 /PRNewswire/ --
Pre-market, Stock-Callers.com highlights the Healthcare sector, withfocus on HealthSouth Corp. (NYSE: HLS), Universal Health Services Inc. (NYSE: UHS), MEDNAX Inc. (NYSE: MD), and LifePoint Health Inc. (NASDAQ: LPNT). According to a NASDAQ report, health care stocks continued to trend lower on Friday,
Last Friday, shares in Birmingham, Alabama headquartered HealthSouth Corp. ended the session 0.79% higher at $42.00. The stock recorded a trading volume of 763,917 shares. The Company's shares have advanced 5.13% in the last one month, 4.41% over the previous three months, and 1.84% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.79% and 4.39%, respectively. Furthermore, shares of HealthSouth, which owns and operates inpatient rehabilitation hospitals, home health agencies, and hospice agencies in the US, have a Relative Strength Index (RSI) of 63.55.
On February 17th, 2017, HealthSouth announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.24 per share, payable on April 17th, 2017, to holders of record on April 03rd, 2017. Access our complete research report on HLS for free at:
Universal Health Services
King of Prussia, Pennsylvania headquartered Universal Health Services Inc.'s stock finished 0.67% higher at $122.95 with a total trading volume of 605,083 shares. The Company's shares have gained 10.02% in the last one month, 2.37% in the previous three months, and 15.58% since the start of this year. The stock is trading above its 50-day moving average by 9.91%. Moreover, shares of Universal Health Services, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers, have an RSI of 79.45.
On February 01st, 2017, Universal Health Services announced that it will report results for its Q4 2016 and full year ended December 31st, 2016 after the market closes on February 28th, 2017. The Company will host a conference call for investors and analysts at 9:00 a.m. ET March 01st, 2017. The complimentary research report on UHS can be downloaded at: http://stock-callers.com/registration/?symbol=UHS
Shares in Sunrise, Florida-based MEDNAX Inc. closed the day 0.42% higher at $70.07. The stock recorded a trading volume of 538,578 shares. The Company's shares have gained 0.29% in the last month, 11.13% over the previous three months, and 5.12% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 2.94% and 3.72%, respectively. Moreover, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 60.15.
On February 08th, 2017, MEDNAX'S net revenue increased by 12.0% to $830.8 million in Q4 2016 from $741.7 million for Q4 2015, driven primarily by contributions from acquisitions completed since October 2015. MEDNAX generated net income of $78.1 million for Q4 2016, or $0.84 per diluted share, based on a weighted average 93.3 million shares outstanding, compared to net income of $92.7 million, or $0.99 per diluted share, for Q4 2015, based on a weighted average 93.5 million shares outstanding. Register for free on Stock-Callers.com and get access to the latest PDF format report on MD at:
Brentwood, Tennessee-based LifePoint Health Inc.'s shares recorded a trading volume of 943,150 shares last Friday, which was higher than their three months average volume of 415,420 shares. The stock closed 1.51% higher at $63.90. The Company's shares have advanced 5.97% in the past month, 14.21% in the previous three months, and 12.50% on an YTD basis. The stock is trading 7.88% above its 50-day moving average and 5.21% above its 200-day moving average. Additionally, shares of LifePoint Health, which through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the US, have an RSI of 69.32.
On February 17th, 2017, LifePoint Health reported consolidated revenues of $1.61 billion, up 17.1% from $1.37 billion in Q4 2015, primarily as a result of its recent acquisitions. The Company's net income for Q4 2016 was $46.6 million, down $8.8 million, or 16.1%, compared to net income of $55.4 million for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc.'s stockholders for Q4 2016 decreased to $1.07 compared to $1.16 in Q4 2015. Download your free research report on LPNT at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Adult immunization is needed for adults whose mandatory childhood vaccines were either missed out ...
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.
Breast Cancer Risk Assessment Calculator predicts the risk for breast cancer. Find list of breast ...View All